Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry.
Brüggenjürgen B, Schliephacke T, Darius H, De Caterina R, Le Heuzey JY, Pittrow D, Reimitz PE, Schilling RJ, Zamorano JL, Kirchhof P. Brüggenjürgen B, et al. Among authors: schliephacke t. Value Health. 2014 Nov;17(7):A473. doi: 10.1016/j.jval.2014.08.1346. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201363 Free article. No abstract available.
Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry.
Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P. Brüggenjürgen B, et al. Among authors: schliephacke t. Value Health. 2014 Nov;17(7):A493. doi: 10.1016/j.jval.2014.08.1464. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201472 Free article. No abstract available.
Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry.
Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P. Brüggenjürgen B, et al. Among authors: schliephacke t. Value Health. 2014 Nov;17(7):A497. doi: 10.1016/j.jval.2014.08.1484. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201497 Free article. No abstract available.
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe.
De Caterina R, Ammentorp B, Darius H, Le Heuzey JY, Renda G, Schilling RJ, Schliephacke T, Reimitz PE, Schmitt J, Schober C, Zamorano JL, Kirchhof P; PREFER in AF Registry Investigators. De Caterina R, et al. Among authors: schliephacke t. Heart. 2014 Oct;100(20):1625-35. doi: 10.1136/heartjnl-2014-305486. Epub 2014 Aug 8. Heart. 2014. PMID: 25106421
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
De Caterina R, Brüggenjürgen B, Darius H, Köhler S, Lucerna M, Pecen L, Renda G, Schilling RJ, Schliephacke T, Zamorano JL, Le Heuzey JY, Kirchhof P. De Caterina R, et al. Among authors: schliephacke t. Arch Cardiovasc Dis. 2018 Feb;111(2):74-84. doi: 10.1016/j.acvd.2017.04.007. Epub 2017 Sep 21. Arch Cardiovasc Dis. 2018. PMID: 28942115 Free article.
Overexpression of Eag1 potassium channels in clinical tumours.
Hemmerlein B, Weseloh RM, Mello de Queiroz F, Knötgen H, Sánchez A, Rubio ME, Martin S, Schliephacke T, Jenke M, Heinz-Joachim-Radzun, Stühmer W, Pardo LA. Hemmerlein B, et al. Among authors: schliephacke t. Mol Cancer. 2006 Oct 5;5:41. doi: 10.1186/1476-4598-5-41. Mol Cancer. 2006. PMID: 17022810 Free PMC article.